Japanese-market 2.5, 5 and 7.5 mg pens. One pricing month = 4 pens.
Book a consultation ↗
Learn about tirzepatide and once-weekly self-injection following medical assessment, including dose adjustment, refrigerated storage and staged dispensing. Weight-management use is off-label and privately paid.
Tirzepatide is a weekly injectable acting on GIP and GLP-1 receptors, with effects on glucose regulation and appetite. The clinic offers doctor-led weight-management consultation. Cosmetic weight reduction differs from GLP-1’s approved Japanese indication.
Assessment includes diabetes, pancreatitis or gallbladder history, gastrointestinal symptoms, hypoglycemia risk, pregnancy or breastfeeding and other medicines—not weight alone. Discuss off-label weight-management use and alternative treatment or lifestyle support.
An initial medical consultation includes self-injection, storage and disposal instructions. It is a weekly subcutaneous injection, but the doctor decides starting dose, increases and pauses. Pricing tiers are not a universal dosing schedule.
Nausea, reduced appetite, constipation or diarrhea may occur. Monitor hydration and nutrition and seek advice when unwell. Refrigerate, avoid freezing and follow the leaflet or pharmacist’s instructions for transport.
Risks include hypoglycemia, especially with other diabetes drugs, acute pancreatitis, gallbladder problems and dehydration. Persistent severe abdominal pain, repeated vomiting, inability to drink or altered awareness require prompt medical care. The clinic states that its off-label use is outside Japan’s drug-injury relief scheme.
This guide combines general information with the clinic’s published menus. Overseas approvals and indications differ from Japan; confirm suitability for the exact product, device and delivery method at consultation.
Tirzepatide is a weekly injectable acting on GIP and GLP-1 receptors, with effects on glucose regulation and appetite. The clinic offers doctor-led weight-management consultation. Cosmetic weight reduction differs from GLP-1’s approved Japanese indication.
Nausea, reduced appetite, constipation or diarrhea may occur. Monitor hydration and nutrition and seek advice when unwell. Refrigerate, avoid freezing and follow the leaflet or pharmacist’s instructions for transport.
Use the fee table on this page to compare the treatment area, quantity, visit count and total price. Prices are in Japanese yen and exclude tax unless stated otherwise. Course prices per visit require the full course contract. Confirm your final quote and treatment suitability with the clinic before proceeding.
Please confirm the current fee when booking. Previous course prices are not presented as current offers.
Contact the clinic
Course price per session = total contract price ÷ number of sessions. It is not a pay-as-you-go price or a monthly instalment. First-visit trials are for new clinic patients only. The doctor determines suitability, number of sessions and intervals. All displayed prices exclude consumption tax, which is charged separately. Tax-exclusive conversions and per-visit equivalents are rounded to the nearest yen. Fees depend on each published plan. Check monitor or first-visit eligibility, area, volume and additional charges.
Bundles are paid in full upfront and dispensed in 1–3-month amounts for cold storage. Undispensed medicine is refundable on discontinuation; dispensed medicine is not returnable. Initial consultation is free; shipping ¥500 excl. tax; confirm the follow-up consultation fee (confirm applicable terms). Delivery requires a Japanese address. Dose changes and step plans require consultation. GLP-1 is approved for type 2 diabetes in Japan; weight-management use is off-label and privately paid.
Price information checked: 22 September 2026. Prices and eligibility may change.
Consultation menus for vitamin, glutathione and other infusions or injections. Evidence, dose and route differ by product; brightening or fatigue relief is not guaranteed. Exosome infusions do not share the evidence or safety profile of routine nutrient replacement.
Check each plan for area, quantity and method.
An IV service using human umbilical-cord-derived stem-cell conditioned medium, not live cells. Review the EV-containing preparation, quality records, unapproved status, costs and risks. Benefits for beauty or health and safety are not established.
6 cc · 12 cc · 20 cc | 1, 5 or 10 visits
11F, HULIC & New GINZA 8
8-9-7 Ginza, Chuo-ku, Tokyo 104-0061, Japan
About 3 min from Shimbashi · About 7 min from Ginza Station
Get directions on Google Maps ↗
